HRX215 - LN3348 | Darizmetinib

Based on 1 reference(s) in Google Scholar 8 10 1

Axon 4195

CAS [2369583-33-3]

MF C21H17F2N5O3S
MW 457.46

  • Purity: 98%
  • Soluble in DMSO

HRX215

Description

HRX215 is a first-in-class, potent, selective and orally active MKK4 inhibitor with an IC50 value of 0.02 µM. HRX215 boosted liver regeneration and prevented liver failure after extensive hepatectomy in pigs.

KEYWORDS: HRX215 | Supplier | MKK4 inhibitor | LN3348 | Darizmetinib | HRX 215 | HRX-215 | LN 3348 | LN-3348 | HRX 0215 | HRX0215 | HRX-0215 | CAS [2369583-33-3] | MAPK | Inhibitor | Enzymes | Liver regeneration | MAP2K

First-in-class, potent, selective and orally active MKK4 inhibitor

Chemical name

N-(2,6-Difluoro-3-(5-(pyridin-4-yl)-1H-pyrazolo[3,4-b]pyridine-3-carbonyl)phenyl)propane-1-sulfonamide

Parent CAS No.

[2369583-33-3]

Order
Size Unit Price Stock
5 mg €180.00 In Stock
25 mg €720.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...